SIRT1 and myocardial ischemia: Because of experimental limitations, we chose only the SIRT1/MAPK pathway and apoptosis mechanism to verify the effects of Sal-B in the treatment of myocardial ischemia-reperfusion, ignoring other pathways and targets.